| J9144 | Injection, daratumumab, 10 mg and hyaluronidase‑fihj | 14,760 | $40 | $560.9K |
| J9271 | Injection, pembrolizumab, 1 mg | 6,800 | $40 | $292.4K |
| J2353 | Injection, octreotide, depot form for intramuscular injection, 1 mg | 780 | $160 | $126.4K |
| J0897 | Injection, denosumab, 1 mg | 2,880 | $20 | $54.7K |
| J9264 | Injection, paclitaxel protein-bound particles, 1 mg | 4,500 | $10 | $45K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 300 | $100 | $29.3K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 310 | $100 | $29.3K |
| 99232 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making or… | 350 | $60 | $21.4K |
| 99233 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 140 | $90 | $13.2K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 170 | $70 | $11.8K |